What are Value Stocks?
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
Below is a list of notable value stocks in the healthcare sector:
- Genesis Healthcare GEN - P/E: 1.63
- Salarius Pharmaceuticals SLRX - P/E: 1.98
- Biogen BIIB - P/E: 8.0
- Coherus BioSciences CHRS - P/E: 9.14
- Lexicon Pharmaceuticals LXRX - P/E: 2.34
Genesis Healthcare has reported Q1 earnings per share at 0.28, which has increased by 380.0% compared to Q4, which was -0.1. Genesis Healthcare does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
This quarter, Salarius Pharmaceuticals experienced an increase in earnings per share, which was -0.44 in Q4 and is now -0.22. Salarius Pharmaceuticals does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
Biogen’s earnings per share for Q2 sits at 10.26, whereas in Q1, they were at 9.14. Biogen does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
This quarter, Coherus BioSciences experienced a decrease in earnings per share, which was 0.53 in Q4 and is now 0.48. Coherus BioSciences does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
This quarter, Lexicon Pharmaceuticals experienced a decrease in earnings per share, which was -0.48 in Q4 and is now -0.63. Lexicon Pharmaceuticals does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.